IL1B and COVID-19: Overall monocyte counts and phenotypes were similar in both groups whereas plasma IL‐1β levels were significantly higher in COVID‐19 patients compared to healthy, SARS‐CoV‐2 naïve controls (Appendix Fig S1B–D).